Reply to the Editor- Functional substrate mapping of ventricular arrhythmia.
作者信息
Vlachos Konstantinos, Frontera Antonio, Benali Karim, Letsas Konstantinos P, Jais Pierre, Santangeli Pasquale
机构信息
IHU LIRYC ANR-10-IAHU-04, Centre Hospitalier Universitaire Bordeaux, Bordeaux, France.
Electrophysiology Unit, De Gasperis Cardio Center, Niguarda Hospital, Milan, Italy.
出版信息
Heart Rhythm O2. 2024 Nov 22;6(2):242-243. doi: 10.1016/j.hroo.2024.11.017. eCollection 2025 Feb.
Abstract
摘要
相似文献
1
Reply to the Editor- Functional substrate mapping of ventricular arrhythmia.
Heart Rhythm O2. 2024 Nov 22;6(2):242-243. doi: 10.1016/j.hroo.2024.11.017. eCollection 2025 Feb.
2
To the Editor- Functional substrate mapping of ventricular arrhythmia.
Heart Rhythm O2. 2024 Nov 22;6(2):242. doi: 10.1016/j.hroo.2024.04.015. eCollection 2025 Feb.
3
Septal Coronary Venous Mapping to Guide Substrate Characterization and Ablation of Intramural Septal Ventricular Arrhythmia.
JACC Clin Electrophysiol. 2019 Jul;5(7):789-800. doi: 10.1016/j.jacep.2019.04.011. Epub 2019 May 8.
4
The value of functional substrate mapping in ventricular tachycardia ablation.
Heart Rhythm O2. 2022 Nov 2;4(2):134-146. doi: 10.1016/j.hroo.2022.10.013. eCollection 2023 Feb.
5
Author's reply to the Letter to the Editor "How to demonstrate the causal relationship between sodium-glucose cotransporter 2 receptor and prevention of ventricular arrhythmia in heart failure cohorts".
J Cardiol. 2025 Jul;86(1):104. doi: 10.1016/j.jjcc.2025.01.012. Epub 2025 Jan 31.
6
Myocardial tissue characterization by cardiac magnetic resonance imaging using T1 mapping predicts ventricular arrhythmia in ischemic and non-ischemic cardiomyopathy patients with implantable cardioverter-defibrillators.
Heart Rhythm. 2015 Apr;12(4):792-801. doi: 10.1016/j.hrthm.2014.12.020. Epub 2014 Dec 19.
7
Reply to the Editor- Effect of Flecainide on Suppression of Ventricular Fibrillation in a Patient With Early Repolarization Syndrome.
Heart Rhythm. 2016 Sep;13(9):e291. doi: 10.1016/j.hrthm.2016.06.016. Epub 2016 Jun 15.
8
Reply to the Editor- Flecainide and Propafenone: Good twins for premature ventricular contractions' killing but not exactly superimposable.
Heart Rhythm. 2018 Sep;15(9):e71. doi: 10.1016/j.hrthm.2018.06.008. Epub 2018 Jun 8.
9
Assessing the Malignant Ventricular Arrhythmic Substrate in Patients With Brugada Syndrome.
J Am Coll Cardiol. 2018 Apr 17;71(15):1631-1646. doi: 10.1016/j.jacc.2018.02.022.
10
Noncontact mapping to guide ablation of right ventricular outflow tract tachycardia.
J Am Coll Cardiol. 2002 Jun 5;39(11):1808-12. doi: 10.1016/s0735-1097(02)01864-8.
本文引用的文献
1
Optimal cardiac rhythm during substrate mapping in scar-related ventricular tachycardia: Significance of wavefront direction on identifying critical sites.
Heart Rhythm. 2024 Aug;21(8):1298-1307. doi: 10.1016/j.hrthm.2024.02.060. Epub 2024 Mar 1.
2
Identification of Human Ventricular Tachycardia Demarcated by Fixed Lines of Conduction Block in a 3-Dimensional Hyperboloid Circuit.
Circulation. 2023 Oct 31;148(18):1354-1367. doi: 10.1161/CIRCULATIONAHA.123.065525. Epub 2023 Aug 28.
3
Repolarization Heterogeneity in Human Post-Infarct Ventricular Tachycardia.
JACC Clin Electrophysiol. 2022 Jun;8(6):713-718. doi: 10.1016/j.jacep.2022.03.002.
4
Does Timing of Ventricular Tachycardia Ablation Affect Prognosis in Patients With an Implantable Cardioverter Defibrillator? Results From the Multicenter Randomized PARTITA Trial.
Circulation. 2022 Jun 21;145(25):1829-1838. doi: 10.1161/CIRCULATIONAHA.122.059598. Epub 2022 Apr 3.
5
Effect of Activation Wavefront on Electrogram Characteristics During Ventricular Tachycardia Ablation.
Circ Arrhythm Electrophysiol. 2019 Jun;12(6):e007293. doi: 10.1161/CIRCEP.119.007293.
6
Infarct-Related Ventricular Tachycardia: Redefining the Electrophysiological Substrate of the Isthmus During Sinus Rhythm.
JACC Clin Electrophysiol. 2018 Aug;4(8):1033-1048. doi: 10.1016/j.jacep.2018.04.007. Epub 2018 Jun 27.
7
Catheter ablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease (VTACH): a multicentre randomised controlled trial.
Lancet. 2010 Jan 2;375(9708):31-40. doi: 10.1016/S0140-6736(09)61755-4.
Zotero 插件